JP2004536842A - トログリタゾンおよびビグアナイドを含むコア製剤 - Google Patents
トログリタゾンおよびビグアナイドを含むコア製剤 Download PDFInfo
- Publication number
- JP2004536842A JP2004536842A JP2003511800A JP2003511800A JP2004536842A JP 2004536842 A JP2004536842 A JP 2004536842A JP 2003511800 A JP2003511800 A JP 2003511800A JP 2003511800 A JP2003511800 A JP 2003511800A JP 2004536842 A JP2004536842 A JP 2004536842A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- core
- troglitazone
- glucopyranosyl
- metformin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/021616 WO2003005993A1 (en) | 2000-05-01 | 2001-07-10 | Core formulation comprising troglitazone and a biguanide |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004536842A true JP2004536842A (ja) | 2004-12-09 |
Family
ID=32067644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003511800A Pending JP2004536842A (ja) | 2001-07-10 | 2001-07-10 | トログリタゾンおよびビグアナイドを含むコア製剤 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1429740A4 (de) |
JP (1) | JP2004536842A (de) |
AU (1) | AU2001273290B2 (de) |
CA (1) | CA2453782A1 (de) |
MX (1) | MXPA04000181A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505903A (ja) * | 2003-09-19 | 2007-03-15 | アンドルックス ラボズ リミテッド ライアビリティ カンパニー | ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416774B1 (en) * | 1996-05-09 | 2002-07-09 | The Trustees Of The University Of Pennsyvania | Hollow bone mineral-like calcium phosphate particles |
US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
WO2000028989A1 (en) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
DE19860699A1 (de) * | 1998-12-30 | 2000-07-06 | Hexal Ag | Pharmazeutische Zusammensetzung |
US6358531B1 (en) * | 1999-02-01 | 2002-03-19 | The Curators Of The University Of Missouri | Method for preparing porous shells or gels from glass particles |
JP2003514011A (ja) * | 1999-11-16 | 2003-04-15 | スミスクライン ビーチャム パブリック リミテッド カンパニー | チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物 |
AR030920A1 (es) * | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
US6451342B2 (en) * | 2000-05-01 | 2002-09-17 | Aeropharm Technology Incorporated | Core formulation comprised of troglitazone and a biguanide |
-
2001
- 2001-07-10 CA CA002453782A patent/CA2453782A1/en not_active Abandoned
- 2001-07-10 MX MXPA04000181A patent/MXPA04000181A/es unknown
- 2001-07-10 JP JP2003511800A patent/JP2004536842A/ja active Pending
- 2001-07-10 AU AU2001273290A patent/AU2001273290B2/en not_active Ceased
- 2001-07-10 EP EP01952549A patent/EP1429740A4/de not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505903A (ja) * | 2003-09-19 | 2007-03-15 | アンドルックス ラボズ リミテッド ライアビリティ カンパニー | ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤 |
JP4718465B2 (ja) * | 2003-09-19 | 2011-07-06 | アンドルックス ラボズ リミテッド ライアビリティ カンパニー | ビグアニドおよびチアゾリジンジオン誘導体を含む新規の医薬製剤 |
Also Published As
Publication number | Publication date |
---|---|
AU2001273290B2 (en) | 2004-10-07 |
EP1429740A4 (de) | 2005-01-26 |
CA2453782A1 (en) | 2003-01-23 |
EP1429740A1 (de) | 2004-06-23 |
MXPA04000181A (es) | 2004-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6524621B2 (en) | Core formulation | |
US6451342B2 (en) | Core formulation comprised of troglitazone and a biguanide | |
US6403121B1 (en) | Core formulation | |
US6780432B1 (en) | Core formulation | |
US6296874B1 (en) | Core formulation comprising troglitazone and abiguanide | |
US20110301172A1 (en) | Combination of dpp-iv inhibitor, ppar antidiabetic and metmorformin | |
BRPI0616694B1 (pt) | Processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis | |
JP2005516919A (ja) | 抗糖尿病製剤および方法 | |
US6461639B2 (en) | Core formulation | |
JP2004536843A (ja) | ピオグリタゾンおよびビグアナイドを含むコア製剤 | |
WO2007007757A1 (ja) | PPARγアゴニストを含有する医薬組成物 | |
JP2004536841A (ja) | コア製剤 | |
AU2001273289A1 (en) | Core formulation comprising pioglitazone hydrochloride and a biguanide | |
ES2290130T3 (es) | Formulacion de nucleo. | |
AU2001273310A1 (en) | A core formulation | |
JP2004536842A (ja) | トログリタゾンおよびビグアナイドを含むコア製剤 | |
AU2001257456A1 (en) | A core formulation | |
AU2001273290A1 (en) | Core formulation comprising troglitazone and a biguanide | |
TWI248815B (en) | The controlled release formulation of metformin HCl | |
ES2366625T3 (es) | Sistema de administración espaciada de fármacos. |